document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center amended restated license agreement style margin margin bottom text indent font size font family time roman this amended restated license agreement this agreement made effective march nbsp effective date between ariad pharmaceutical delaware corporation with principal place business landsdowne street cambridge ariad bellicum pharmaceutical delaware corporation with place business fannin suite houston bellicum ariad bellicum each hereafter referred individually party together party style margin margin bottom text indent font size font family time roman whereas ariad owner otherwise control certain proprietary licensed patent right licensed technology each defined below style margin margin bottom text indent font size font family time roman whereas bellicum owns otherwise control bellicum patent right bellicum technology defined below style margin margin bottom text indent font size font family time roman whereas party ariad gene therapeutic agti previously entered into that certain license agreement dated july nbsp agreement under which ariad bellicum each granted certain license other subject term condition agreement style margin margin bottom text indent font size font family time roman whereas agti merged into ariad style margin margin bottom text indent font size font family time roman whereas ariad certain right pursuant with including exclusive license certain intellectual property separate right enter negotiation obtain exclusive license intellectual property both case involving style margin margin bottom text indent font size font family time roman whereas bellicum desire that ariad waive right pursue exclusive license intellectual property relating that bellicum obtain license that intellectual property from style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style page break before always size style color width align center style margin margin bottom text indent font size font family time roman whereas bellicum desire convert exclusive license licensed patent right licensed technology under agreement exclusive license develop commercialize licensed product defined below expand primary indication which such exclusive license will apply style margin margin bottom text indent font size font family time roman whereas party desire amend restate agreement entirety effective date forth this agreement style margin margin bottom text indent font size font family time roman therefore consideration mutual covenant contained herein other good valuable consideration receipt adequacy which hereby acknowledged party hereby agree follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign definition table style margin margin bottom text indent font size font family time roman whenever used agreement with initial capital letter term defined this article shall have meaning specified style margin margin bottom text indent font size font family time roman additional indication shall mean each specific cancer indication other than which bellicum elect include licensed field pursuant provision section style margin margin bottom text indent font size font family time roman affiliate shall mean corporation firm limited liability company partnership other entity that directly control controlled under common control with party this agreement purpose this section nbsp control mean ownership directly indirectly through more affiliate fifty percent nbsp more share stock entitled vote election director case corporation fifty percent nbsp more equity interest case other type legal entity status general partner partnership other arrangement whereby party control right control board director equivalent governing body corporation other entity style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman adverse event shall mean untoward medical occurrence patient subject administered licensed product whether considered related licensed product including without limitation undesirable sign including abnormal laboratory finding clinical concern symptom disease temporally associated with such licensed product style margin margin bottom text indent font size font family time roman antigen shall mean molecule that cause immune system response style margin margin bottom text indent font size font family time roman ariad data shall have meaning forth section style margin margin bottom text indent font size font family time roman ariad dimerizer shall mean compound known analog derivative dimerizer salt thereof where composition matter thereof divalent ligand time during primary license term within scope claim patent patent application within licensed patent right style margin margin bottom text indent font size font family time roman ariad dimerizer product shall mean nbsp ariad dimerizer nbsp licensed product which dimerization effected with ariad dimerizer style margin margin bottom text indent font size font family time roman ariad indemnitees shall have meaning forth section style margin margin bottom text indent font size font family time roman ariad product shall mean product nbsp that comprises incorporates ariad dimerizer ariad dimerizer nbsp that comprises cell transfected with both limited gene antigen gene inducible costimulatory molecule where gene inducible costimulatory molecule activated using ariad dimerizer ariad dimerizer style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman ariad regulatory information shall have meaning forth section style margin margin bottom text indent font size font family time roman shall mean style margin margin bottom text indent font size font family time roman ariad technology shall mean technology resulting from experiment conducted with material provided pursuant agreement whether quantity such material used experiment were manufactured ariad including without limitation technology known other technology disclosed patent application patent listed licensed patent right covering ariad technology schedule style margin margin bottom text indent font size font family time roman agreement shall mean each nbsp between ariad nbsp between ariad nbsp between ariad nbsp between ariad nbsp between ariad nbsp between ariad each amended which collectively cover inter alia ariad technology style margin margin bottom text indent font size font family time roman bellicum data shall have meaning forth section style margin margin bottom text indent font size font family time roman bellicum indemnitees shall have meaning forth section style margin margin bottom text indent font size font family time roman bellicum information shall have meaning forth section style margin margin bottom text indent font size font family time roman bellicum patent right shall mean patent right controlled bellicum original effective date during period from original effective date through term which necessary useful development manufacture sale offer sale import ariad product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman dimerizer including ariad dimerizer ariad dimerizer provided however that bellicum patent right include patent right claiming nbsp nbsp composition matter antigen inducible costimulatory molecule nbsp composition matter product treatment regime process using product comprising dendritic cell transfected with both nbsp gene antigen peptide protein that antigen that induces expression antigen nbsp gene inducible costimulatory molecule where such product dimerizer activate gene that part such product nbsp method manufacture such antigen inducible costimulatory molecule product described clause nbsp treatment regime process using such product bellicum patent right excludes patent right licensed bellicum ariad that cover ariad technology style margin margin bottom text indent font size font family time roman bellicum regulatory information shall have meaning forth section style margin margin bottom text indent font size font family time roman bellicum technology shall mean technology whether patentable controlled bellicum original effective date during period from original effective date through term which necessary useful practice patent patent application included bellicum patent right necessary useful development manufacture sale offer sale import ariad product dimerizer including ariad dimerizer ariad dimerizer bellicum technology includes without limitation nbsp bellicum information described section nbsp provided however that bellicum technology include technology specifically pertaining nbsp antigen inducible costimulatory molecule nbsp product treatment regime process using product comprising dendritic cell transfected with both nbsp gene antigen peptide protein that antigen that induces expression antigen nbsp gene inducible costimulatory molecule style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman where such product dimerizer activate gene that part such product nbsp manufacture such antigen inducible costimulatory molecule product described clause nbsp treatment regime process using such product bellicum technology excludes technology licensed bellicum ariad that cover ariad technology style margin margin bottom text indent font size font family time roman shall mean biologics license application defined title united state code federal regulation amended from time time filed with seeking regulatory approval market sell licensed product united state particular indication within licensed field style margin margin bottom text indent font size font family time roman cell transplantation indication shall mean nbsp gvhd nbsp other acute chronic adverse clinical effect human being resulting from transplantation bone marrow hematopoietic stem cell that treated inducing apoptosis transplanted cell nbsp case bone marrow hematopoietic stem cell product transplantation that includes cell containing gene coding inducible caspase disease condition human being that treated such product where such treatment lead indication subsection nbsp style margin margin bottom text indent font size font family time roman common stock shall mean nbsp common stock value share bellicum nbsp other security into which which security described foregoing clause nbsp converted exchanged pursuant plan recapitalization reorganization merger consolidation sale asset other similar transaction style margin margin bottom text indent font size font family time roman competition shall mean with respect licensed product sold bellicum affiliate sublicensee thereof given country that more third party selling product same indication which product nbsp would infringe valid claim licensed patent right listed part schedule style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman expiration those licensed patent right that country nbsp contains same equivalent applicable regulatory authority standard active pharmaceutical ingredient contained such licensed product such country nbsp sale such product represent least percent total market share volume sale such product licensed product such country calendar quarter measured reputable published data such country reference market share data collected style margin margin bottom text indent font size font family time roman confidential information shall mean with respect party receiving party information which disclosed other party disclosing party receiving party hereunder employee consultant affiliate licensee sublicensees except extent that receiving party demonstrate written record other suitable physical evidence that such information nbsp date disclosure demonstrably known receiving party affiliate other than virtue prior confidential disclosure such party affiliate nbsp date disclosure subsequently becomes publicly known through fault omission receiving party nbsp obtained from third party having lawful right make such disclosure free from obligation confidentiality disclosing party nbsp independently developed receiving party without reference reliance upon confidential information disclosing party style margin margin bottom text indent font size font family time roman confidentiality agreement shall have meaning forth section style margin margin bottom text indent font size font family time roman control controlled shall mean with respect patent right technology possession party ability grant license sublicense such patent right technology provided herein without violating term arrangement agreement between such party third party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman convertible security shall mean stock note warrant option other security including without limitation option entitling holder convert exercise exchange such security ascertainable number share common stock avoidance doubt note shall deemed convertible security unless until they repaid maturity date defined note warrant shall deemed convertible security until they become exercisable style margin margin bottom text indent font size font family time roman dimerizer shall mean molecule that analog that induces interaction proximity more protein modified contain dimerizer binding domain resulting activation specific cell signaling gene transcription protein secretion event cultured cell whole animal human style margin margin bottom text indent font size font family time roman drug approval application shall mean application regulatory approval including pricing reimbursement approval required prior commercial sale licensed product country jurisdiction territory including without limitation equivalent application regulatory approval filed with other regulatory authority required prior commercial sale licensed product country jurisdiction territory style margin margin bottom text indent font size font family time roman equity financing shall mean bona fide issuance sale common stock convertible security other than upon grant exercise option style margin margin bottom text indent font size font family time roman existing bellicum product shall have meaning forth section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman expansion period shall have meaning forth section style margin margin bottom text indent font size font family time roman first commercial sale shall mean country country basis date first length transaction transfer disposition value third party nbsp licensed product behalf bellicum affiliate bellicum sublicensee such country nbsp ariad product behalf ariad affiliate sublicensee ariad such country style margin margin bottom text indent font size font family time roman shall mean united state food drug administration successor agency authority thereto style margin margin bottom text indent font size font family time roman gvhd shall mean clinical condition involving acute chronic adverse effect symptom resulting from allogenic transplantation bone marrow hematopoietic stem cell into human being which engrafted donor cell attack patient organ tissue which treated activating cell signaling leading apoptosis transplanted cell style margin margin bottom text indent font size font family time roman shall mean style margin margin bottom text indent font size font family time roman shall mean style margin margin bottom text indent font size font family time roman improvement shall mean invention discovery created otherwise controlled ariad bellicum during period from original effective date through term which constitutes enhancement modification invention within licensed technology licensed patent right together with patent right technology that claim cover such invention discovery provided however that improvement include nbsp antigen inducible stimulatory molecule nbsp product treatment regime process using product comprising nbsp dendritic cell transfected with both gene antigen peptide protein that antigen that induces style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman expression antigen nbsp gene inducible costimulatory molecule where such product dimerizer activate gene that part such product nbsp method manufacture such antigen inducible stimulatory molecule product described clause nbsp treatment regime process using such product each case patent right technology that claim cover such invention discovery style margin margin bottom text indent font size font family time roman shall mean investigational drug application defined title united state code federal regulation amended from time time filed filed with with regard licensed product style margin margin bottom text indent font size font family time roman indemnitees indemnifying party shall have meaning forth section style margin margin bottom text indent font size font family time roman inducible caspase shall mean icasp casp another molecule that will activate signaling leading apoptosis purpose this definition following term shall have meaning forth following literature reference style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign table style margin margin bottom text indent font size font family time roman inducible costimulatory molecule shall mean itlr another molecule that will activate signaling leading maturation activation dendritic cell including chimera foregoing purpose this definition following term shall have meaning forth following literature reference style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman licensed field shall mean treatment prevention progression occurrence human primary indication additional indication extent permitted under section nbsp cancer indication provided section nbsp case style margin margin bottom text indent font size font family time roman licensed patent right shall mean nbsp patent right controlled ariad original effective date during primary license term which necessary useful development manufacture sale offer sale import licensed product dimerizers used incorporated licensed product including without limitation patent right covering ariad technology nbsp patent right whether controlled ariad that listed schedule attached hereto made part hereof regardless ownership such patent right licensed patent right effective date listed schedule attached hereto made part hereof which shall updated necessary from time time ariad written notice bellicum style margin margin bottom text indent font size font family time roman licensed product shall mean nbsp cancer vaccine whether used prophylactically therapeutically manufacture sale import administration activation other which covered claim patent right technology which patent right technology controlled bellicum affiliate including without limitation patent right licensed assigned bellicum that cover ariad technology either nbsp containing both limited nbsp gene antigen other antigen directed indication within licensed field nbsp more gene inducible costimulatory molecule nbsp containing dendritic cell transfected with both limited nbsp gene antigen other antigen directed indication within licensed field nbsp more gene inducible costimulatory molecule nbsp containing nbsp peptide protein that antigen other antigen directed style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman indication within licensed field that induces expression antigen other antigen directed indication within licensed field nbsp dendritic cell transfected with more gene inducible costimulatory molecule where such case nbsp encoded inducible costimulatory molecule activated upon dimerization using dimerizer nbsp gene cell transfected with such gene coding inducible caspase either alone combination with other adjuvant gene such where gene coding such inducible caspase activated upon dimerization dimerizer nbsp dimerizers with product described clause nbsp nbsp this section nbsp nbsp treatment regimen process utilizing product described clause nbsp nbsp this section nbsp provided however that event licensed field expanded pursuant section nbsp include cancer indication clause nbsp this section nbsp shall include vaccine described therein directed such indication well cancer vaccine style margin margin bottom text indent font size font family time roman licensed technology shall mean include technology whether patentable controlled ariad original effective date during primary license term which nbsp necessary useful practice patent patent application included licensed patent right including without limitation patent right controlled ariad covering ariad technology nbsp necessary useful practice license granted bellicum hereunder licensed technology includes ariad regulatory information ariad know trade secret including limited following technology manufacture dimerizers optimum choice synthetic route optimized process step parameter analytic method using authentic standard control chemical chiral purity through manufacturing path background data supporting chemical chiral proof structure intermediate structural identification impurity characteristic this route their hplc characteristic qualification these impurity regulatory purpose style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman loss shall have meaning forth section style margin margin bottom text indent font size font family time roman shall mean application filed with relevant regulatory authority europe seeking regulatory approval market sell licensed product europe country territory therein particular indication within licensed field style margin margin bottom text indent font size font family time roman shall mean drug application defined title united state code federal regulation amended from time time filed with seeking regulatory approval market sell licensed product united state particular indication within licensed field style margin margin bottom text indent font size font family time roman sale shall mean gross invoiced sale price each licensed product sold bellicum affiliate sublicensees third party throughout territory following amount incurred paid bellicum affiliate sublicensees with respect sale licensed product style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman sale shall include sale transfer between bellicum affiliate sublicensees unless licensed product consumed affiliate sublicensee sale disposition licensed product clinical clinical study compassionate sale shall also disregarded purpose calculating sale style margin margin bottom text indent font size font family time roman ariad dimerizer shall mean dimerizer other than ariad dimerizer that time during primary license term within scope claim other than claim covering composition matter thereof divalent ligand including without limitation manufacture claim patent patent application within licensed patent right style margin margin bottom text indent font size font family time roman ariad dimerizer product shall mean nbsp ariad dimerizer nbsp licensed product which dimerization effected with ariad dimerizer style margin margin bottom text indent font size font family time roman cancer expansion period shall have meaning forth section style margin margin bottom text indent font size font family time roman cancer negotiation period shall have meaning forth section nbsp style margin margin bottom text indent font size font family time roman note shall mean series style margin margin bottom text indent font size font family time roman option shall mean option other security granted issued pursuant stock plan style margin margin bottom text indent font size font family time roman original effective date shall mean july nbsp style margin margin bottom text indent font size font family time roman orphan drug designation shall mean request designation treatment gvhd orphan drug under that been granted under style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman patent right shall mean patent patent application including without limitation certificate invention application certification invention registered design registered design application industrial design industrial design application registration reissue reexamination extension substitution confirmation registration revalidations renewal term restoration addition provisionals continuation continuation part division continued prosecution application request continued examination thereof style margin margin bottom text indent font size font family time roman phase clinical trial shall mean particular licensed product lawful study human safety dose ranging such licensed product which prospectively designed generate sufficient data successful commence phase clinical trial such licensed product style margin margin bottom text indent font size font family time roman phase clinical trial shall have meaning forth section style margin margin bottom text indent font size font family time roman phase clinical trial shall mean particular licensed product particular indication controlled lawful study human safety dose ranging efficacy such licensed product such indication which prospectively designed generate sufficient data successful commence phase clinical trial such licensed product such indication style margin margin bottom text indent font size font family time roman phase clinical trial shall have meaning forth section style margin margin bottom text indent font size font family time roman phase clinical trial shall mean particular licensed product particular indication controlled lawful study human safety efficacy such licensed product such indication which prospectively designed demonstrate statistically whether such licensed product safe effective such indication manner sufficient file regulatory approval market sell that licensed product united state indication under investigation such study style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman primary indication shall mean nbsp nbsp cell transplantation indication style margin margin bottom text indent font size font family time roman primary license term shall mean with respect each licensed product period commencing original effective date continuing country country product product basis until later nbsp last expire valid claim covering composition matter licensed product component thereof manufacture licensed field licensed product component thereof nbsp twelve nbsp year from date first commercial sale such country style margin margin bottom text indent font size font family time roman qualified financing shall mean last equity financing result which bellicum will have received cumulative gross proceeds from more equity financing equal least dollar style margin margin bottom text indent font size font family time roman analog shall mean compound which analog derivative that induces formation complex with mutant other variant thereof fusion protein containing part respectively their respective mutant other variant style margin margin bottom text indent font size font family time roman regulatory approval shall mean approval including pricing reimbursement approval product establishment license registration authorization kind other regulatory authority necessary development clinical human clinical testing manufacture quality testing supply storage importation export transport marketing sale licensed product component thereof licensed field country other jurisdiction territory regulatory approval shall include without limitation other drug approval application style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman regulatory authority shall mean applicable supranational national federal state local regulatory agency department bureau other governmental entity country jurisdiction including united state having responsibility such country jurisdiction regulatory approval kind such country jurisdiction successor agency authority thereto style margin margin bottom text indent font size font family time roman shall mean board trustee style margin margin bottom text indent font size font family time roman agreement shall have meaning forth section style margin margin bottom text indent font size font family time roman shall mean licensed patent right licensed technology licensed ariad under agreement include style margin margin bottom text indent font size font family time roman stock plan shall mean bellicum stock option plan amended other plan adopted bellicum issuance equity security option acquire equity security employee consultant director advisor bellicum style margin margin bottom text indent font size font family time roman sublicensee shall mean third party whom bellicum grant sublicense some right licensed patent right licensed technology granted bellicum under this agreement style margin margin bottom text indent font size font family time roman technology shall mean include unpatented proprietary idea invention discovery confidential information biologic material data result formula design specification method process formulation technique idea know technical information including without limitation style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman structural functional information trade secret process information clinical information clinical information proprietary biological chemical pharmacological toxicological clinical clinical assay control manufacturing data material style margin margin bottom text indent font size font family time roman term shall have meaning forth section style margin margin bottom text indent font size font family time roman territory shall mean country jurisdiction world style margin margin bottom text indent font size font family time roman third party shall mean person entity other than bellicum ariad their respective affiliate style margin margin bottom text indent font size font family time roman valid claim shall mean claim issued unexpired patent pending patent application that been pending since first substantive office action relevant patent office such patent application within licensed patent right including without limitation patent right covering ariad technology controlled ariad that nbsp been finally cancelled withdrawn abandoned rejected administrative agency other body competent jurisdiction nbsp been revoked held invalid declared unpatentable unenforceable decision court other body competent jurisdiction that unappealable unappealed within time allowed appeal nbsp been rendered unenforceable through disclaimer otherwise nbsp lost nbsp through interference proceeding style margin margin bottom text indent font size font family time roman warrant shall mean warrant common stock issued connection with note style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign grant right table style margin margin bottom text indent font size font family time roman license bellicum style margin margin bottom text indent font size font family time roman grant license ariad hereby grant bellicum exclusive even ariad royalty bearing license including right grant sublicenses accordance with section nbsp under licensed patent right licensed technology ariad interest improvement subject time restriction obligation under agreement with respect nbsp research develop test obtain regulatory approval make have made have used sell offer sale have sold import have imported export have exported licensed product including without limitation dimerizer included nbsp utilized therein territory within licensed field during term subject term condition this agreement nbsp make have made import export each case solely research purpose including clinical enabling toxicology other clinical study conduct clinical trial with respect obtain regulatory approval sell commercialize licensed product including without limitation dimerizer included utilized therein nbsp indication other than primary indication until expansion period nbsp bellicum elect additional indication licensed field during expansion period indication other than primary indication additional indication until font style white space nowrap cancer font expansion period bellicum pursuant license granted under section nbsp include patient with clinical trial licensed product intended where antigen psma bellicum file seek regulatory approval such licensed product then bellicum seek regulatory approval such licensed product treatment prevention progression occurrence human bellicum receives regulatory approval such licensed product treatment prevention progression occurrence human then licensed field shall include style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman expansion licensed field obtain additional exclusive right bellicum exercise right expand request expansion exclusive license granted section nbsp follows style margin margin bottom text indent font size font family time roman during period commencing continuing thereafter expansion period bellicum bellicum election additional indication licensed field delivering written notice ariad which describes each specific cancer indication included additional indication state that cancer indication other than included additional indication style margin margin bottom text indent font size font family time roman within period commencing later occur nbsp bellicum exercise option expand licensed field include additional indication pursuant section nbsp nbsp bellicum affiliate sublicensee commencing cancer expansion period bellicum bellicum election request that ariad agree expand licensed field specific cancer indication other than cell transplantation indication delivering written notice ariad within such cancer expansion period which describes specific product associated product development plan capability resource specific cancer disease condition desire include within licensed field upon receipt such written notice ariad shall good faith consider bellicum request ariad willing expand licensed field party will negotiate with respect possible amendment this agreement setting forth relevant term including milestone royalty pertaining expansion period from date ariad receipt written request cancer negotiation period party agree upon term style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman condition mutually acceptable both party before expiration such cancer negotiation period despite their respective good faith effort then bellicum shall have further right with respect such expansion ariad shall have further obligation negotiate pursuant this section nbsp style margin margin bottom text indent font size font family time roman certain exclusivity right notwithstanding anything contrary this agreement style margin margin bottom text indent font size font family time roman ariad will license sublicense third party develop commercialize itself together with third party treatment prevention nbsp primary indication nbsp additional indication which bellicum elect include licensed field pursuant provision section nbsp cancer indication other than cell transplantation indication that included licensed field pursuant provision section nbsp dimerizer other product involving dimerizer covered bellicum patent right bellicum technology patent right covering ariad technology licensed ariad original effective date during primary license term style margin margin bottom text indent font size font family time roman bellicum will develop except permitted pursuant license granted section nbsp manufacture promote sell dimerizer outside licensed field effect from time time provided however that extent bellicum demonstrates ariad reasonable satisfaction that label nbsp licensed product outside licensed field occurred complete absence promotion thereof behalf request with approval bellicum affiliate their director officer consultant clinical investigator such label shall constitute violation this provision this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman right sublicense subcontract bellicum shall have right grant sublicenses affiliate sublicensee portion right under license granted pursuant section nbsp provided however that nbsp such sublicense under license granted pursuant section nbsp shall granted connection with license patent right technology controlled bellicum which necessary useful manufacture sale licensed product covered sublicense nbsp sublicense include right further sublicense unless provided prior written consent bellicum ariad allowing such further sublicense requested bellicum ariad will assist bellicum obtaining such consent from such sublicenses shall subject subordinate consistent with term condition agreement with respect sublicenses nbsp ariad shall notified grant sublicense potential sublicenses nbsp sublicenses shall subject consistent with term condition this agreement nbsp bellicum shall remain obligated payment ariad payment obligation hereunder including without limitation payment royalty described section nbsp hereof nbsp upon termination this agreement such sublicense shall considered direct license from ariad provided section nbsp nbsp bellicum shall provide ariad with copy each such sublicense agreement from which bellicum redact confidential term that necessary disclose ariad purpose confirming compliance with this agreement agreement within execution addition bellicum shall have right subcontract with third party including provided that third party manufacturer shall subject approval ariad commercially reasonable discretion have such third party perform work bellicum behalf pursuant license granted pursuant section nbsp term which subject consistent with term condition this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman technology transfer ariad disclosed bellicum after original effective date shall disclose bellicum from time time during primary license term licensed patent right licensed technology matter disclosed delivered bellicum pursuant this section nbsp outlined schedule such trade secret technology disclosed delivered bellicum ariad hereunder basis ariad make representation warranty that such trade secret technology that reasonably necessary practice license granted bellicum hereunder their fitness such purpose style margin margin bottom text indent font size font family time roman ariad regulatory information subject applicable governing patient confidentiality extent necessary bellicum sublicensee comply with applicable statute regulation ordinance guideline governing regulatory approval licensed product ariad shall provide bellicum sublicensee nbsp summary right cross reference safety data including adverse event reported regulatory authority ariad relating nbsp copy clinical investigator brochure protocol clinical study report connection with phase study conducted ariad nbsp summary relevant data generated ariad connection with nbsp preclinical study ariad data collectively ariad regulatory information ariad regulatory information shall treated confidential information ariad bellicum sublicensee shall maintain such ariad data disclosed pursuant this section nbsp confidence shall disclose third party other than nbsp bellicum sublicensee itself through agent provide cross reference ariad data reported ariad under filing obtain regulatory approval licensed product using country disclose ariad data written submission such regulatory authority each case solely required obtain regulatory approval style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman nbsp licensed product licensed field only after obtaining prior written permission from ariad make such disclosure which conditioned upon bellicum nbsp sublicensee obtaining written assurance from regulatory authority whom information being disclosed that such ariad data will afforded confidential treatment such regulatory authority nbsp bellicum sublicensee upon prior written notice ariad verbally disclose ariad data teleconference meeting with regulatory authority each case solely required obtain regulatory approval licensed product licensed field only after obtaining prior written permission from ariad which conditioned upon affording appropriate ariad personnel opportunity participate each such teleconference meeting style margin margin bottom text indent font size font family time roman transfer orphan drug designation subject applicable statute regulation ordinance guideline governing transfer orphan drug designation good valuable consideration receipt sufficiency which hereby acknowledged ariad hereby transfer assigns conveys ownership beneficial interest orphan drug designation bellicum effective effective date within nbsp business after effective date nbsp ariad bellicum shall each submit required information effect change named sponsor orphan drug designation from ariad bellicum accordance with applicable statute regulation ordinance guideline nbsp ariad shall transfer complete copy orphan drug designation including amendment supplement thereto correspondence regarding orphan drug designation bellicum ariad shall cooperate reasonably with bellicum requested bellicum bellicum expense bellicum effort maintain orphan drug designation style margin margin bottom text indent font size font family time roman reservation right between party ariad shall retain ownership license right right title interest licensed style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman patent right licensed technology other license either express implied implication estoppel granted hereunder with respect technology patent right ariad licensors except expressly stated this section nbsp ariad reserve right same bellicum acknowledges that inventor identified agreement each retain right respectively nbsp practice solely commercial research purpose nbsp publish information included nbsp provide tangible material included academic profit research institution under term material transfer agreement subject restriction agreement that right shall granted invention technology incorporating utilizing such material commercial purpose bellicum acknowledges that subject including obligation that licensed product that would licensed product under agreement sold produced united state manufactured substantially united state bellicum acknowledges that subject certain obligation forth agreement complete copy which obligation ariad provided bellicum style margin margin bottom text indent font size font family time roman agreement applicable intended third party beneficiary this section section this agreement such party have right bring suit equity matter governed subject such provision agreement terminated then from after effective date such termination license granted ariad bellicum under shall deemed direct license from bellicum obligation bellicum under this agreement with regard such license under obligation ariad under agreement with regard licensed product defined herein developed made used sold bellicum affiliate sublicensee bellicum that would licensed product under agreement including payment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman royalty shall deemed obligation bellicum long bellicum materially breached material obligation condition that would entitle ariad terminate this agreement ariad will voluntarily terminate willfully breach agreement addition specific provision this agreement relating agreement provision article agreement with bellicum substituted agti such provision expressly included this agreement benefit extent provision article agreement cover same subject matter other provision this agreement relating agreement provision imposing greatest obligation bellicum shall apply style margin margin bottom text indent font size font family time roman license ariad style margin margin bottom text indent font size font family time roman grant license style margin margin bottom text indent font size font family time roman bellicum hereby grant ariad exclusive royalty free subject only section nbsp license including right grant sublicenses under bellicum patent right bellicum technology bellicum interest improvement develop make have made have used sell offer sale have sold import have imported export have exported ariad product including product comprising utilizing outside licensed field subject term condition this agreement event will ariad practice bellicum patent right bellicum technology bellicum interest improvement excluding improvement licensed bellicum ariad that cover ariad technology within licensed field sell offer sale have sold import have imported export have exported ariad product including product comprising utilizing outside licensed field such ariad product nbsp same regulatory purpose licensed product listed schedule style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman pursuant section nbsp prior ariad commencement development thereof that being developed commercialized ariad knowledge bellicum affiliate sublicensees within licensed field existing bellicum product event that bellicum filed particular licensed product within after such licensed product listed schedule nbsp then foregoing prohibition shall apply such licensed product notwithstanding foregoing ariad shall free develop make have made have used sell offer sale have sold import have imported export have exported dimerizer purpose without restriction except that ariad shall sell offer sale have sold import have imported export have exported dimerizer covered bellicum patent right that specifically labeled ariad with existing bellicum product style margin margin bottom text indent font size font family time roman bellicum patent right bellicum technology licensed bellicum third party would require payment such third party upon ariad practice thereof pursuant license granted under this section nbsp then bellicum shall notify ariad writing promptly after obtaining license ariad written notice bellicum provided time prior first commercial sale ariad product utilizing subject matter bellicum patent right bellicum technology licensed bellicum third party nbsp elect accept license such bellicum patent right bellicum technology which case ariad shall responsible making payment such third party resulting from ariad practice such bellicum patent right bellicum technology pursuant license granted under this section nbsp shall provide bellicum written notice confirming that made such payment fails make such payment accordance with term agreement with such third party license such bellicum patent right bellicum technology under this section nbsp shall terminate nbsp elect decline license such bellicum patent right bellicum technology style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman shall deemed decline license such bellicum patent right bellicum technology provide bellicum written notice election forth above which case such bellicum patent right bellicum technology shall excluded from license granted ariad under this section nbsp style margin margin bottom text indent font size font family time roman bellicum regulatory information facilitate development ariad product ariad sublicensee pursuant license granted under this section nbsp subject applicable governing patient confidentiality extent necessary ariad sublicensee comply with applicable statute regulation ordinance guideline governing regulatory approval ariad product bellicum shall provide shall require sublicensees provide ariad sublicensee nbsp right cross reference safety data including adverse event reported bellicum under relating licensed product using nbsp copy investigator safety letter provided bellicum clinical investigator connection with clinical study licensed product using nbsp summary relevant data generated bellicum connection with preclinical study licensed product using bellicum data collectively bellicum regulatory information bellicum regulatory information should treated confidential information bellicum ariad sublicensee shall maintain such bellicum data disclosed pursuant this section nbsp confidence shall disclose third party other than nbsp ariad sublicensee themselves through their agent provide cross reference bellicum data reported bellicum under corresponding foreign country filing obtain regulatory approval ariad product using country disclose bellicum data written submission such regulatory authority each case solely required obtain regulatory approval ariad product using outside licensed field only after obtaining prior written permission from bellicum make such style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman disclosure which conditioned upon ariad sublicensee obtaining written assurance from regulatory authority whom information being disclosed that such bellicum data will afforded confidential treatment such regulatory authority nbsp ariad sublicensee upon prior written notice bellicum verbally disclose bellicum data teleconference meeting with regulatory authority each case solely required obtain regulatory approval ariad product using pursuant license granted section nbsp only after obtaining prior written permission from bellicum which conditioned upon affording appropriate bellicum personnel opportunity participate each such teleconference meeting style margin margin bottom text indent font size font family time roman reservation right between party bellicum shall retain ownership license right right title interest bellicum patent right bellicum technology other license either express implied implication estoppel granted hereunder with respect technology patent right bellicum licensors except expressly stated this section nbsp bellicum reserve right same style margin margin bottom text indent font size font family time roman development commercialization licensed product style margin margin bottom text indent font size font family time roman commercialization style margin margin bottom text indent font size font family time roman responsibility from after original effective date bellicum shall have full control authority over development commercialization licensed product licensed field territory including without limitation nbsp clinical development activity including pharmaceutical development work formulation process development relating licensed product nbsp activity related human clinical trial including clinical study nbsp activity relating manufacture supply licensed style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman product including required process development scale work with respect thereto nbsp marketing promotion sale distribution import export activity relating licensed product nbsp activity relating regulatory filing registration application regulatory approval relating foregoing including inds foreign equivalent manufacturing facility validation licensure drug approval application other regulatory approval bellicum shall data result other information arising from such activity bellicum with respect licensed product licensed field territory under this agreement including without limitation regulatory filing registration application regulatory approval relating licensed product including inds foreign equivalent drug approval application other regulatory approval collectively bellicum information foregoing bellicum information shall considered confidential information technology solely owned bellicum bellicum information which necessary useful development manufacture sale offer sale import dimerizer including ariad dimerizer ariad dimerizer ariad product shall included bellicum technology subject license granted ariad section nbsp activity relating development commercialization licensed product under this agreement shall undertaken bellicum sole cost expense except otherwise expressly provided this agreement style margin margin bottom text indent font size font family time roman diligence bellicum will exercise commercially reasonable effort diligence developing commercializing least licensed product that cancer vaccine described clause nbsp section nbsp licensed product that gene cell transfected with such gene coding inducible caspase described clause nbsp section nbsp undertaking investigation action required obtain regulatory approval necessary market such licensed product licensed field territory taking into account competitiveness style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman marketplace proprietary position licensed product relative potential safety efficacy licensed product cost good availability capacity manufacture supply licensed product commercial scale profitability applicable licensed product other relevant factor including without limitation technical legal scientific medical factor style margin margin bottom text indent font size font family time roman update report style margin margin bottom text indent font size font family time roman update report bellicum shall update schedule each time bellicum sublicensee determines manufacture have manufactured quality licensed product toxicology study potential licensed product shall furnish such updated schedule ariad bellicum shall provide ariad with written report frequently than during term summarizing bellicum effort develop commercialize licensed product hereunder such report shall include minimum information sufficient enable satisfy reporting requirement united state government shall contain tabulation result clinical trial clinical plan summary result preclinical clinical study relating licensed product then preceding half year bellicum shall provide ariad with least prior written notice intended filing prior public disclosure such filing bellicum extent bellicum aware sublicensee with other regulatory authority equivalent application with regard licensed product drug approval application intended commencement bellicum clinical trial licensed product will notify ariad such filing commencement clinical trial within after such filing made such clinical trial commenced addition bellicum shall provide ariad with prompt written notice occurrence first commercial sale licensed product country addition such report bellicum agrees nbsp upon request ariad provide ariad with copy document submitted style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman received from regulatory authority relating licensed product including without limitation inds their foreign equivalent correspondence from regulatory authority nbsp provide ariad with adverse event information product complaint information relating licensed product compiled prepared bellicum normal course business connection with development commercialization sale licensed product within time frame consistent with reporting obligation under applicable regulation report update adverse event product complaint other information provided party other party under this agreement including under this section nbsp shall considered confidential information disclosing party subject term section nbsp hereof style margin margin bottom text indent font size font family time roman manufacturing bellicum shall have right manufacture have manufactured such quantity dimerizer require order develop commercialize licensed product pursuant term this agreement bellicum will notify ariad writing intent manufacture have manufactured third party dimerizer least prior commencement manufacture itself through third party upon ariad request time party will negotiate good faith supply agreement under which ariad will provide rolling forecast anticipated need such dimerizer which agreed number month will binding provided that under such supply agreement either nbsp bellicum will commercially reasonable effort supply quantity dimerizer ordered ariad will supply such dimerizer ariad ariad licensee price equal fully burdened manufacturing cost plus percent nbsp third party manufacture such dimerizer bellicum then bellicum shall nbsp procure ariad affiliate licensee right purchase such dimerizers from third party term favorable than those granted bellicum giving ariad affiliate licensee equal priority with style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman respect quantity lead time delivery such dimerizers given bellicum affiliate sublicensees nbsp grant such third party license patent right technology controlled bellicum without bellicum incurring additional expense obligation third party licensors bellicum required order third party supply ariad ariad licensee with such dimerizers addition supply agreement will provide that bellicum third party manufacturer fails supply dimerizer required thereby bellicum third party manufacturer will transfer ariad designee technology necessary manufacture such dimerizer will grant necessary license ariad designee royalty basis style margin margin bottom text indent font size font family time roman compliance with each party shall comply with applicable rule regulation guideline including without limitation rule guideline institution which work relevant this agreement licensed product conducted rule guideline relevant professional society including without limitation american society gene therapy style margin margin bottom text indent font size font family time roman payment royalty style margin margin bottom text indent font size font family time roman payment royalty royalty rate minimum royalty style margin margin bottom text indent font size font family time roman initial payment consideration nbsp conversion bellicum license from exclusive license exclusive license nbsp inclusion cell transplantation indication primary indication consequent grant bellicum exclusive license cell transplantation indication bellicum agrees ariad refundable amount hundred fifty thousand dollar within style margin margin bottom text indent font size font family time roman royalty payment consideration nbsp grant license ariad under this agreement nbsp licensed technology orphan style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman drug designation provided transferred hereunder subject other term this agreement including remainder this section nbsp bellicum shall ariad royalty annual sale such licensed product percentage rate follows style margin margin bottom margin left font size font family time roman subject section nbsp nbsp below commencing date first commercial sale each licensed product each country territory continuing until expiration primary license term with respect such licensed product style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap annual sale valign bottom nbsp nbsp valign bottom align center ariad nbsp dimerizer product valign bottom nbsp valign bottom align center ariad dimerizer nbsp product bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center table style margin margin bottom margin left font size font family time roman either nbsp only remaining valid claim with respect such licensed product country claim patent right covering technology there competition nbsp valid claim covering composition matter such licensed product component thereof licensed field such licensed product component thereof such country have expired primary license term with regard such licensed product such country expired there competition then following royalty rate shall instead apply until primary license term with regard such licensed product such country style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width style font family time roman font size valign bottom annual sale valign bottom nbsp nbsp valign bottom align center ariad nbsp dimerizer product valign bottom nbsp valign bottom align center ariad dimerizer nbsp product bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman valid claim covering composition matter such licensed product component thereof licensed field such licensed product component thereof such country have expired primary license term with regard such licensed product expired there competition then consideration licensed technology orphan drug designation provided transferred hereunder following royalty rate shall instead apply until primary license term with regard such licensed product such country style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width style font family time roman font size valign bottom annual sale valign bottom nbsp nbsp valign bottom align center ariad nbsp dimerizer product valign bottom nbsp valign bottom align center ariad dimerizer nbsp product bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center nbsp valign bottom nbsp valign bottom align center nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center nbsp valign bottom nbsp valign bottom align center nbsp table style margin margin bottom text indent font size font family time roman following expiration primary license term with regard licensed product country bellicum shall have fully paid perpetual irrevocable license under section nbsp with regard such licensed product such country style margin margin bottom text indent font size font family time roman milestone payment bellicum shall make following milestone payment ariad within after occurrence following event style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom event valign bottom nbsp nbsp valign bottom align center payment bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center table style margin margin bottom text indent font size font family time roman event milestone payable upon occurrence shall payable bellicum nbsp upon commencement nbsp upon commencement provided that foregoing shall apply licensed product commenced prior effective date style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman event milestone payable upon occurrence commencement shall payable bellicum upon commencement milestone payable upon occurrence commencement shall payable bellicum upon later nbsp commencement nbsp date which during after such when style margin margin bottom text indent font size font family time roman royalty payment certain third party royalty payment owed payable with respect licensed product university pursuant that certain between ariad gene therapeutic amended from time time agreement shall sole responsibility obligation ariad other royalty other payment owed payable with respect licensed product including without limitation royalty other payment will sole responsibility obligation bellicum style margin margin bottom text indent font size font family time roman acknowledgement bellicum recognizes acknowledges that each following separately together substantial economic benefit bellicum nbsp ariad expertise concerning discovery understanding dimerizers dimerization technology nbsp license granted bellicum hereunder with respect licensed technology that within claim licensed patent right nbsp license granted bellicum under licensed patent right nbsp orphan drug designation transferred bellicum hereunder nbsp exclusivity which afforded bellicum each foregoing party agree that royalty rate forth section nbsp reflect fair reasonable blended allocation value provided ariad bellicum regardless whether particular licensed product utilizes ariad dimerizer covered licensed patent right style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman payment term style margin margin bottom text indent font size font family time roman payment royalty unless otherwise expressly provided bellicum shall make license royalty payment owed ariad hereunder arrears within from each quarter which such payment accrues purpose determining when sale licensed product occurs under this agreement sale shall deemed occur earlier nbsp nbsp date each royalty payment shall accompanied report each country territory which sale licensed product occurred calendar quarter covered such statement specifying gross sale available sale each country currency applicable royalty rate under this agreement royalty payable including accounting deduction taken calculation sale applicable exchange rate convert from each country currency united state dollar under this section nbsp royalty payable united state dollar style margin margin bottom text indent font size font family time roman overdue payment subject other term this agreement payment paid within time period forth this section nbsp shall bear interest rate percent from date until paid full provided that event shall said annual rate exceed maximum interest rate permitted regard such payment such payment when made shall accompanied interest accrued said interest payment acceptance thereof shall negate waive right ariad other remedy legal equitable which entitled because delinquency payment style margin margin bottom text indent font size font family time roman accounting payment hereunder shall made bellicum united state united state dollar conversion foreign currency united state dollar shall made conversion rate existing united state reported last business quarter immediately preceding applicable calendar quarter cease published then rate exchange used shall that reported such other business publication national circulation united state party reasonably agree style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman withholding restriction payment payment hereunder shall made free clear duty levy charge except withholding extent applicable bellicum shall make applicable withholding payment behalf ariad shall provide ariad with such written documentation regarding such payment available bellicum relating application ariad foreign credit such payment with united state internal revenue service style margin margin bottom text indent font size font family time roman record retention review style margin margin bottom text indent font size font family time roman royalty commencing date first commercial sale first licensed product hereunder bellicum affiliate sublicensees shall keep least from calendar year which they pertain complete accurate record sale bellicum affiliate sublicensees case each licensed product sufficient detail allow accuracy payment hereunder confirmed style margin margin bottom text indent font size font family time roman review subject other term this section nbsp request ariad which shall made more frequently than during term upon least prior written notice from ariad expense ariad except otherwise provided herein bellicum shall permit independent certified public accountant reasonably selected ariad reasonably acceptable bellicum inspect during regular business hour relevant record required maintained bellicum under this section nbsp provided record reviewed more than once under this section nbsp result such review shall binding both party absent manifest error ariad agrees treat result such accountant review record under this section nbsp confidential information style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman bellicum subject term section nbsp review reveals deficiency calculation payment royalty bellicum then nbsp bellicum shall promptly ariad amount remaining paid nbsp such underpayment percent more bellicum shall reasonable pocket cost expense incurred ariad connection with review review reveals overpayment royalty bellicum ariad shall promptly remit such overpaid amount bellicum style margin margin bottom text indent font size font family time roman other party bellicum shall include agreement with affiliate sublicensees term requiring such party retain record required this section nbsp permit ariad inspect such record required this section nbsp style margin margin bottom text indent font size font family time roman initial issuance common stock party hereby acknowledge that connection with agreement pursuant stock purchase agreement dated july nbsp between party bellicum issued ariad ariad received share common stock which share common stock constituted after giving effect such issuance percent bellicum share common stock fully diluted basis july nbsp style margin margin bottom text indent font size font family time roman treatment confidential information style margin margin bottom text indent font size font family time roman confidential obligation mutual disclosure agreement between party dated october nbsp confidentiality agreement shall apply information provided under this agreement each party shall take such action shall cause affiliate sublicensees take such action preserve confidentiality each other confidential information would customarily take preserve confidentiality confidential information using such circumstance than reasonable care prevent confidential information style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman other party from being copied used disclosed third party without other party prior written consent except those third party whom disclosure confidential information permitted pursuant term confidentiality agreement extent conflict between provision this article confidentiality agreement provision this article shall control pertain information provided under this agreement confidentiality agreement retroactive october nbsp style margin margin bottom text indent font size font family time roman limited disclosure ariad bellicum each agree that disclosure other party confidential information officer employee consultant agent other party affiliate sublicensees shall made only extent necessary carry right responsibility under this agreement shall limited maximum extent possible consistent with such right responsibility shall only made extent such person bound written confidentiality obligation maintain confidentiality thereof such confidential information except expressly permitted this agreement ariad bellicum each further agree disclose transfer other party confidential information third party under circumstance without prior written approval from other party such approval unreasonably withheld except otherwise required except otherwise expressly permitted this agreement each party disclose confidential information other party investor prospective investor lender other potential financing source third party conducting diligence connection with financing acquisition transaction obligated keep such information confidential each party upon request other party will return confidential information disclosed transferred other party pursuant this agreement including copy extract document manifestation whatever form within such request earlier termination expiration style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman this agreement provided however that party retain nbsp confidential information other party relating license which expressly survives such termination nbsp nbsp copy other confidential information inactive archive solely purpose establishing content thereof style margin margin bottom text indent font size font family time roman publicity neither party publicly disclose existence term other matter fact regarding this agreement without prior written consent other party which consent shall unreasonably withheld delayed provided however that nbsp either party issue press release upon execution hereof nbsp either party make such disclosure nbsp extent required requirement nationally recognized security exchange quotation system over counter market which such party security listed traded nbsp investor prospective investor lender other potential financing source obligated keep such information confidential provided that event that such disclosure required under clause this section nbsp disclosing party shall provide other party with notice beforehand extent reasonably practical coordinate with other party with respect wording timing such disclosure nbsp ariad disclose filing bellicum sublicensee with other regulatory authority equivalent application commencement bellicum sublicensee clinical trial provided that ariad only disclose such filing commencement sublicensee nbsp nbsp bellicum sublicensee make prior public disclosure such filing commencement nbsp ariad provides bellicum with notice beforehand extent reasonably practical coordinate with bellicum with respect wording timing such disclosure nbsp sublicensee consent bellicum sublicensee intend make prior public disclosure such filing commencement bellicum will notify araiad with notice thereof pursuant section nbsp will good faith effort obtain style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman consent sublicensee ariad make such disclosure once press release other written statement approved disclosure both party either party make subsequent public disclosure content such statement without further approval other party style margin margin bottom text indent font size font family time roman name neither party shall employ name other party name promotional material advertising without prior express written permission other party style margin margin bottom text indent font size font family time roman notwithstanding anything contrary this agreement ariad disclose term this agreement bellicum confidential information including term bellicum sublicense reasonable necessary required fulfill obligation under agreement style margin margin bottom text indent font size font family time roman provision concerning filing prosecution maintenance patent right style margin margin bottom text indent font size font family time roman patent filing prosecution maintenance enforcement ariad shall have sole right obligation prepare file prosecute obtain maintain first right enforce licensed patent right excluding patent right licensed bellicum that cover ariad technology event that ariad elect enforce licensed patent right alleged infringement licensed field with product that that comprises cell transfected with both limited gene antigen more gene inducible costimulatory molecule where gene gene inducible costimulatory molecule activated using ariad dimerizer ariad dimerizer bellicum sole expense provided that licensed patent right alleged infringed patent other than licensed patent right covering ariad technology bellicum only with advance written consent ariad which granted withheld style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman ariad sole discretion bellicum recover collect keep damage collected result such enforcement bellicum bellicum shall have sole right obligation prepare file prosecute obtain maintain enforce bellicum patent right between bellicum ariad bellicum shall have sole right prepare file prosecute obtain maintain patent right licensed bellicum that cover ariad technology accordance with term condition agreed upon between bellicum subject right granted time bellicum affiliate sublicensees event that bellicum elect enforce bellicum patent right ariad only expense only with advance written consent bellicum which granted withheld bellicum sole discretion ariad recover collect keep damage collected result such enforcement ariad extent bellicum assumes enforcement licensed patent right ariad assumes enforcement bellicum patent right under this section nbsp later elect enforce such right such party will notify other party writing promptly upon such election enforce event least prior deadline submit filing related thereto style margin margin bottom text indent font size font family time roman representation warranty style margin margin bottom text indent font size font family time roman ariad representation ariad represents warrant bellicum that style margin margin bottom text indent font size font family time roman execution delivery this agreement performance transaction contemplated hereby have been duly authorized appropriate ariad corporate action will require consent approval ariad stockholder style margin margin bottom text indent font size font family time roman this agreement legal valid obligation binding upon ariad enforceable accordance with term execution delivery performance this agreement party conflict with agreement instrument understanding which ariad party which bound style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman ariad full right legal capacity grant right granted bellicum hereunder without violating right third party style margin margin bottom text indent font size font family time roman ariad provided true complete copy agreement each agreement bellicum ariad material default agreement agreement style margin margin bottom text indent font size font family time roman royalty other payment under agreement between ariad third party result license granted ariad herein practice right granted bellicum hereunder other than remuneration which pursuant agreement agreement style margin margin bottom text indent font size font family time roman bellicum representation bellicum represents warrant ariad that style margin margin bottom text indent font size font family time roman execution delivery this agreement performance transaction contemplated hereby have been duly authorized appropriate bellicum corporate action will require consent approval bellicum stockholder style margin margin bottom text indent font size font family time roman this agreement legal valid obligation binding upon bellicum enforceable accordance with term execution delivery performance this agreement party conflict with agreement instrument understanding which bellicum party which bound style margin margin bottom text indent font size font family time roman bellicum full right legal capacity grant right granted ariad hereunder without violating right third party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman royalty other payment under agreement between bellicum third party result license granted bellicum herein practice right granted ariad hereunder style margin margin bottom text indent font size font family time roman bellicum knowledge after investigation owner patent right listed schedule under part ariad technology except right patent patent application entitled induced activation dendritic cell said part schedule which were partially released inventor licensed bellicum inventor license agreement dated effective date bellicum nbsp filed patent application nbsp internal patent disclosure similar document nbsp license from except license agreement dated that each case relates product other discovery invention conceived reduced practice using proprietary material provided under agreement including without limitation other dimerizer analog regardless whether quantity such proprietary material actually used were manufactured ariad bellicum style margin margin bottom text indent font size font family time roman warranty style margin margin bottom text indent font size font family time roman nothing this agreement shall construed style margin margin bottom text indent font size font family time roman warranty representation either party validity scope patent application patent licensed hereunder style margin margin bottom text indent font size font family time roman warranty representation that anything made used sold otherwise disposed under license granted pursuant this agreement will free from infringement patent copyright other right third party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman warranty representation ariad that information trade secret technology provided ariad bellicum under license granted pursuant this agreement sufficient practice licensed patent right granted hereunder style margin margin bottom text indent font size font family time roman warranty representation regarding nbsp obligation ariad bring prosecute action suit against third party infringement nbsp granting implication estoppel otherwise license right under patent other right other person other than regardless whether such patent other right dominant subordinate licensed patent right style margin margin bottom text indent font size font family time roman except expressly forth this agreement neither party make representation extends warranty kind either express implied there express implied warranty merchantability fitness particular purpose infringement patent copyright trademark other right third party other implied warranty style margin margin bottom text indent font size font family time roman indemnification style margin margin bottom text indent font size font family time roman indemnification style margin margin bottom text indent font size font family time roman bellicum indemnity bellicum shall indemnify defend hold harmless ariad their respective affiliate director officer employee stockholder agent inventor identified license agreement each their respective successor heir assigns affiliate their respective director officer employee stockholder agent their respective successor heir assigns ariad indemnitees from against style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman liability damage loss expense including reasonable attorney expense litigation collectively loss incurred imposed upon such ariad indemnitees them connection with third party claim suit action demand judgment including without limitation personal injury product liability matter extent arising nbsp development testing production manufacture supply promotion import sale person licensed product component thereof manufactured sold bellicum affiliate sublicensee under this agreement nbsp gross negligence willful misconduct part bellicum affiliate sublicensees except extent that such loss attributable breach ariad representation warranty covenant forth this agreement gross negligence willful misconduct ariad indemnitee style margin margin bottom text indent font size font family time roman ariad indemnity subject section nbsp above ariad shall indemnify defend hold harmless bellicum affiliate sublicensees their respective director officer employee agent their respective successor heir assigns bellicum indemnitees from against loss incurred imposed upon such bellicum indemnitees them connection with third party claim suit action demand judgment including without limitation personal injury product liability matter extent arising nbsp development testing production manufacture supply promotion import sale person ariad product component thereof manufactured sold ariad affiliate ariad sublicensee under this agreement nbsp gross negligence willful misconduct part ariad affiliate sublicensees except extent that such loss attributable breach bellicum representation warranty covenant forth this agreement gross negligence willful misconduct bellicum indemnitee style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman indemnification procedure event that ariad indemnitee bellicum indemnitee each indemnitee seeking indemnification under section nbsp above from party indemnifying party indemnitee shall notify indemnifying party such claim with respect such indemnitee soon reasonably practicable after indemnitee receives notice claim indemnitee shall permit indemnifying party assume direction control defense claim including right settle claim solely monetary consideration shall cooperate reasonably requested expense indemnifying party defense claim indemnification obligation under article shall apply harm suffered direct result delay notice indemnifying party hereunder amount paid settlement claim demand action other proceeding such settlement effected without consent indemnifying party which consent shall withheld delayed unreasonably indemnitee employee agent shall reasonably cooperate with indemnifying party legal representative investigation claim demand action other proceeding covered section style margin margin bottom text indent font size font family time roman limitation liability except liability third party under section nbsp neither party affiliate licensors shall liable other special consequential incidental indirect damage arising this agreement however caused under theory liability style margin margin bottom text indent font size font family time roman term termination style margin margin bottom text indent font size font family time roman term expiration term this agreement shall commence upon effective date shall expire upon expiration last primary license term unless terminated forth herein term style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman termination right breach style margin margin bottom text indent font size font family time roman termination breach subject other term this agreement this agreement right option granted herein terminated either party upon material breach other party material obligation condition effective thirty nbsp after giving written notice breaching party such termination case payment breach ninety nbsp after giving written notice breaching party such termination case other breach which notice shall describe such breach reasonable detail foregoing notwithstanding such default breach cured remedied shown existent within aforesaid thirty nbsp ninety nbsp period notice shall automatically withdrawn effect style margin margin bottom text indent font size font family time roman voluntary termination bellicum shall have right terminate this agreement time after nbsp year from effective date event that bellicum determines develop commercialize licensed product style margin margin bottom text indent font size font family time roman termination bankruptcy event that either party file protection under bankruptcy make assignment benefit creditor appoints suffers appointment receiver trustee over property file petition under bankruptcy insolvency such petition filed against which discharged within sixty nbsp filing thereof then other party terminate this agreement effective immediately upon written notice such party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman effect termination upon termination this agreement ariad bellicum under section nbsp bellicum pursuant section nbsp effective date such termination relevant license sublicenses granted ariad bellicum shall terminate automatically upon termination this agreement ariad bellicum under section nbsp bellicum pursuant section nbsp subject applicable statute regulation ordinance guideline governing transfer orphan drug designation similar designation jurisdiction orphan drug status bellicum will transfer assign convey ownership beneficial interest orphan drug designation similar designation jurisdiction orphan drug status ariad effective date termination within nbsp such termination ariad bellicum shall each submit required information other relevant regulatory authority effect change named sponsor orphan drug designation similar designation jurisdiction orphan drug status from bellicum ariad accordance with applicable statute regulation ordinance guideline bellicum shall transfer complete copy orphan drug designation similar designation jurisdiction orphan drug status including amendment supplement thereto correspondence relating thereto ariad termination this agreement shall affect ariad right pursuant investor right agreement dated july nbsp amended except stated therein notwithstanding foregoing subject time provision agreement with respect extent license under such granted bellicum under this agreement nbsp such termination this agreement shall construed termination valid sublicense sublicensee hereunder thereafter each such sublicensee shall considered direct licensee ariad provided that nbsp such sublicensee then full compliance with term condition sublicense nbsp accrued payment obligation such sublicensee style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman ariad have been paid nbsp such sublicensee agrees writing assume applicable obligation bellicum under this agreement arising thereafter extent scope sublicense nbsp bellicum affiliate sublicensees shall have right nbsp month such longer time period which party mutually agree writing sell otherwise dispose licensed product then hand with royalty paid ariad sale such licensed product provided this agreement style margin margin bottom text indent font size font family time roman remedy except otherwise expressly forth this agreement termination provision this article addition other relief remedy available either party style margin margin bottom text indent font size font family time roman surviving provision notwithstanding provision herein contrary right obligation party forth section last sentence with respect event occurring before termination sale after termination permitted section nbsp period stated therein well right obligation otherwise accrued hereunder including accrued payment obligation shall survive expiration termination term without limiting generality foregoing bellicum shall have obligation make milestone royalty payment ariad that accrued prior effective date termination this agreement shall remain liable such payment obligation accruing prior effective date such termination style margin margin bottom text indent font size font family time roman dispute style margin margin bottom text indent font size font family time roman negotiation party recognize that bona fide dispute certain matter from time time arise during term that relates either party right obligation hereunder event occurrence such dispute either party written notice other party have such dispute style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman referred their respective senior official designated below their successor attempted resolution good faith negotiation within after such notice received said designated senior official follows style margin margin bottom font size font family time roman bellicum chief executive officer style margin margin bottom font size font family time roman ariad chief executive officer style margin margin bottom text indent font size font family time roman event designated senior official able resolve such dispute within period either party invoke provision section nbsp style margin margin bottom text indent font size font family time roman arbitration subject section nbsp dispute controversy claim initiated either party arising resulting from relating this agreement performance either party obligation under this agreement other than bona fide third party action proceeding filed instituted action proceeding third party against party whether before after termination this agreement shall finally resolved binding arbitration whenever party shall decide institute arbitration proceeding shall give written notice that effect other party such arbitration shall conducted under commercial arbitration rule american arbitration association panel three arbitrator appointed accordance with such rule such arbitration shall held boston massachusetts method manner discovery such arbitration proceeding shall governed state york arbitrator shall have authority grant injunction specific performance allocate between party cost arbitration such equitable manner they determine judgment upon award rendered entered court having jurisdiction application made such court judicial acceptance award order enforcement case event shall demand arbitration made after date when institution legal equitable proceeding based upon such style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman claim dispute other matter question would barred applicable statute limitation notwithstanding foregoing either party shall have right without waiving right remedy available such party under this agreement otherwise seek obtain from court competent jurisdiction interim provisional relief that necessary desirable protect right property such party pending selection arbitrator hereunder pending arbitrator determination dispute controversy claim hereunder style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miscellaneous table style margin margin bottom text indent font size font family time roman insurance style margin margin bottom text indent font size font family time roman extent long licensed bellicum under section nbsp required agreement bellicum shall comply with term this section nbsp bellicum shall comply through insurance written reputable financially secure insurance carrier with statutory worker compensation employer liability requirement covering employee with respect activity performed under this agreement addition foregoing bellicum shall maintain comprehensive general liability insurance including product liability insurance covering bellicum indemnification obligation hereunder with reputable financially secure insurance carrier cover activity bellicum affiliate sublicensees such insurance shall provide minimum limit liability considered standard bellicum industry prior human clinical trial commencing with human clinical trial licensed product bellicum shall maintain such insurance with minimum limit liability dollar occurrence dollar aggregate shall include ariad their respective trustee director officer employee student agent additional insured such insurance shall written cover claim incurred discovered manifested made during after term style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman ariad request bellicum shall furnish certificate insurance evidencing primary coverage requiring prior written notice cancellation material change ariad bellicum shall advise ariad writing that maintains excess liability coverage following form over primary insurance least minimum limit forth above such insurance bellicum shall primary coverage insurance above additional insured shall excess noncontributory ariad acknowledges that insurance specified this section nbsp become unavailable unavailable commercially practicable term such event ariad agrees discus with bellicum commercially reasonable alternative each party shall carry appropriate insurance covering such party indemnification obligation under this agreement through insurance written reputable financially secure insurance carrier style margin margin bottom text indent font size font family time roman notification notice request other communication hereunder shall writing shall addressed receiving party address forth below such other address party designate notice hereunder shall either nbsp delivered hand nbsp made facsimile transmission followed with written confirmation nbsp sent private courier service providing evidence receipt nbsp sent registered certified mail return receipt requested postage prepaid address other contact information party follows style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign style margin left text indent font size font family time roman nbsp nbsp ariad valign bottom valign bottom style margin margin bottom font size font family time roman ariad pharmaceutical style margin margin bottom font size font family time roman landsdowne street style margin margin bottom font size font family time roman cambridge style margin margin bottom font size font family time roman attn chief executive officer style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman with nbsp nbsp copy nbsp valign bottom valign bottom style margin margin bottom font size font family time roman mintz levin cohn ferris glovsky style margin margin bottom font size font family time roman popeo style margin margin bottom font size font family time roman financial center style margin margin bottom font size font family time roman boston style margin margin bottom font size font family time roman attn jeffrey wiesen table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign nbsp nbsp bellicum valign bottom valign bottom style margin margin bottom font size font family time roman bellicum pharmaceutical style margin margin bottom font size font family time roman fannin suite style margin margin bottom font size font family time roman houston style margin margin bottom font size font family time roman attn chief executive officer style font size height height colspan style font family time roman font size valign with nbsp nbsp copy nbsp valign bottom valign bottom style margin margin bottom font size font family time roman cooley style margin margin bottom font size font family time roman eastgate mall style margin margin bottom font size font family time roman diego style margin margin bottom font size font family time roman attn chandler table style margin margin bottom text indent font size font family time roman notice request other communication hereunder shall deemed have been given either nbsp hand time delivery thereof receiving party address such party forth above nbsp made telecopy facsimile transmission time that receipt thereof been acknowledged recipient nbsp sent private courier such notice delivered recipient nbsp sent registered certified mail fifth nbsp business following such mailing made style margin margin bottom text indent font size font family time roman language this agreement been prepared english language english language shall control interpretation style margin margin bottom text indent font size font family time roman governing this agreement will construed interpreted applied accordance with state york excluding body controlling conflict style margin margin bottom text indent font size font family time roman limitation except expressly forth this agreement neither party grant other party right license intellectual property style margin margin bottom text indent font size font family time roman entire agreement this agreement together with confidentiality agreement constitute entire agreement between party with respect subject matter hereof supersede prior representation understanding agreement between party with respect subject matter style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman hereof ariad bellicum agree that agreement amended restated entirety forth this agreement effective date that agreement effect from original effective date until effective date modification shall effective unless writing with specific reference this agreement signed party style margin margin bottom text indent font size font family time roman waiver term condition this agreement waived only written instrument executed party waiving compliance failure either party time time require performance provision hereof shall manner affect right later time enforce same waiver either party condition term shall deemed continuing waiver such condition term another condition term style margin margin bottom text indent font size font family time roman heading section subsection heading inserted convenience reference only form part this agreement style margin margin bottom text indent font size font family time roman assignment neither this agreement right obligation hereunder assigned delegated otherwise transferred whole part either party without prior express written consent other provided however that either party without written consent other assign this agreement right delegate obligation sublicense right hereunder affiliate connection with transfer sale substantially such party asset business related this agreement event merger consolidation change control similar transaction event such transaction however intellectual property right acquiring party such transaction other than party this agreement shall included technology licensed hereunder permitted assignee shall assume obligation assignor under this agreement purported assignment violation this section nbsp shall void term condition this agreement shall binding upon inure benefit permitted successor assigns party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman force majeure neither party shall liable failure delay performing obligation forth this agreement neither shall deemed breach obligation such failure delay natural disaster cause beyond reasonable control such party event such force majeure party affected thereby shall reasonable effort cure overcome same resume performance obligation hereunder style margin margin bottom text indent font size font family time roman construction party hereto acknowledge agree that nbsp each party counsel reviewed negotiated term provision this agreement have contributed revision nbsp rule construction effect that ambiguity resolved against drafting party shall employed interpretation this agreement nbsp term provision this agreement shall construed fairly party hereto favor against party regardless which party generally responsible preparation this agreement style margin margin bottom text indent font size font family time roman severability provision this agreement become invalid ruled illegal court competent jurisdiction deemed unenforceable under then current applicable from time time effect during term hereof intention party that remainder this agreement shall affected thereby provided that party right under this agreement materially affected party hereto covenant agree renegotiate such term covenant application thereof good faith order provide reasonably acceptable alternative term covenant condition this agreement application thereof that invalid illegal unenforceable being intent party that basic purpose this agreement effectuated style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman status nothing this agreement intended shall deemed constitute partner agency employer employee joint venture relationship between party style margin margin bottom text indent font size font family time roman section nbsp license granted under this agreement deemed purpose section nbsp bankruptcy code license right intellectual property defined section nbsp such code party agree that bellicum fully exercise right election under bankruptcy code regardless whether either party file bankruptcy united state other jurisdiction party further agree that event bellicum elect retain right licensee under such code bellicum shall entitled complete access technology licensed hereunder embodiment such technology such embodiment technology shall delivered bellicum later than style margin margin bottom text indent font size font family time roman commencement bankruptcy proceeding against licensor upon written request unless licensor elect perform obligation under agreement style margin margin bottom text indent font size font family time roman delivered under section nbsp above upon rejection this agreement behalf bellicum upon written request style margin margin bottom text indent font size font family time roman export compliance each party affiliate sublicensees shall comply with united state regulation controlling export certain commodity technical data including without limitation export administration regulation united state department commerce among other thing these regulation prohibit require license export certain type commodity technical data specified country bellicum hereby give written assurance that will comply with will cause affiliate sublicensees comply with united state export control regulation that bear sole responsibility violation such regulation itself affiliate sublicensees that will indemnify defend hold ariad harmless accordance with section nbsp consequence such violation style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman further assurance each party agrees execute acknowledge deliver such further instruction such other necessary appropriate order carry purpose intent this agreement style margin margin bottom text indent font size font family time roman counterpart this agreement executed simultaneously more counterpart each which shall deemed original which together shall constitute same instrument style margin margin bottom font size font family time roman align center signature page follows style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman witness whereof party have caused this agreement executed their duly authorized representative nbsp original style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign colspan bellicum pharmaceutical valign bottom valign bottom colspan ariad pharmaceutical style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom valign bottom thomas farrell valign bottom valign bottom valign bottom valign bottom harvey berger style font family time roman font size valign valign bottom valign bottom thomas farrell valign bottom valign bottom valign bottom valign bottom harvey berger style font family time roman font size valign title valign bottom valign bottom chief executive officer valign bottom valign bottom title valign bottom valign bottom chairman chief executive officer table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule licensed patent right style margin margin bottom font size font family time roman table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign bottom colspan nowrap align center font style font size font style font family time roman font size valign bottom nowrap align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign bottom style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom table style font size margin margin bottom nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom colspan nowrap font style font size font bgcolor cceeff style font family time roman font size valign bottom style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom table style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align right schedule style margin margin bottom font size font family time roman align center licensed product style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign formerly gmax table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign caspacide donor lymphocyte infusion table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman portion this exhibit indicated mark were omitted have been filed separately with security exchange commission pursuant registrant application requesting confidential treatment pursuant rule nbsp security exchange amended style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center body html text document